Table 6. Estimated national and regional vaccination costs and cost-effectiveness of rotavirus vaccine introduction in a cohort of children in Nigeria over the first five years of life.
‘Average Nigeria perspective’ incremental cost-effectiveness ratio (ICER) base case estimates assumed Gavi subsidies for the first 5 years of vaccine introduction. ‘Full price’ is the cost of the vaccine from the perspective of Gavi.
| Average Nigeria Perspective Vaccination Costs (2019 US$ / 1,000 births) | Gavi Perspective Vaccination Costs (2019 US$ / 1,000 births) | Average Nigeria Perspective ICER (2019 US$ / DALY averted) | Gavi Perspective ICER (2019 US$ / DALY averted) | |
|---|---|---|---|---|
| NATIONAL | 2,667 (1,924; 3,760) | 3,185 (2,389; 4,291) | 47 (18; 105) | 62 (29; 130) |
| REGION | ||||
| North Central | 2,927 (2,108; 4,120) | 3,495 (2,626; 4,719) | 48 (19; 116) | 68 (31; 144) |
| North East | 1,520 (1,098; 2,123) | 1,815 (1,355; 2,439) | 41 (21; 82) | 51 (28; 98) |
| North West | 1,024 (733; 1,441) | 1,223 (910; 1,649) | 25 (10; 56) | 33 (15; 68) |
| South East | 4,877 (3,519; 6,834) | 5,824 (4,356; 7,886) | 58 (26; 122) | 74 (37; 149) |
| South South | 4,253 (3,060; 5,982) | 5,078 (3,798; 6,896) | 64 (18; 157) | 88 (35; 191) |
| South West | 4,519 (3,240; 6,390) | 5,397 (4,055; 7,305) | 47 (12; 118) | 66 (26; 148) |